# Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma

> **NCT00907348** · PHASE2 · UNKNOWN · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 49 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma
- Follicular Lymphoma

## Interventions

- **DRUG:** LR-CHOP21

## Key facts

- **NCT ID:** NCT00907348
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** 2009-10
- **Final completion:** 2012-01
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2011-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907348, "Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00907348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*